The United States Patent Trial and Appeal Board has handed a win to Chinese-American synthetic biologist Feng Zhang (張鋒) and his team from the Massachusetts Institute of Technology (MIT) in a dispute over patents of the gene editing technology known as CRISPR.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
Local governments may face scrutiny over PRC-national ward chiefs
11/20/2025 10:48 PM - Business
Taiwan's October export orders see ninth consecutive annual gain
11/20/2025 09:51 PM - Society
Taipei police probe online threat to bomb multiple school campuses
11/20/2025 09:18 PM - Politics
Germany 'deeply concerned' over China probe into Puma Shen: Envoy
11/20/2025 08:54 PM - Politics
Cabinet approves amendments to revenue allocation law
11/20/2025 08:37 PM